Collier Financial Buys Shares of 116 The Cigna Group (NYSE:CI)

Collier Financial bought a new stake in The Cigna Group (NYSE:CI) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 116 shares of the health services provider’s stock, valued at approximately $32,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Ulland Investment Advisors LLC increased its position in shares of The Cigna Group by 2,500.0% during the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after acquiring an additional 100 shares during the period. Prospera Private Wealth LLC purchased a new stake in shares of The Cigna Group during the third quarter worth $37,000. ORG Wealth Partners LLC purchased a new position in The Cigna Group in the fourth quarter valued at $34,000. Harbor Capital Advisors Inc. purchased a new position in The Cigna Group in the third quarter valued at $45,000. Finally, Heck Capital Advisors LLC purchased a new position in The Cigna Group in the fourth quarter valued at $53,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Royal Bank of Canada dropped their target price on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Wells Fargo & Company dropped their target price on The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating on the stock in a report on Tuesday, February 4th. StockNews.com lowered The Cigna Group from a “buy” rating to a “hold” rating in a report on Friday, January 31st. Sanford C. Bernstein downgraded shares of The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price objective for the company. in a research note on Thursday, February 6th. Finally, Morgan Stanley decreased their price objective on shares of The Cigna Group from $403.00 to $379.00 and set an “overweight” rating for the company in a research note on Friday, January 31st. Three analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, The Cigna Group presently has an average rating of “Moderate Buy” and an average target price of $373.69.

The Cigna Group Trading Up 2.1 %

Shares of The Cigna Group stock opened at $292.74 on Tuesday. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The stock has a market cap of $81.42 billion, a PE ratio of 23.92, a price-to-earnings-growth ratio of 0.94 and a beta of 0.54. The company has a 50-day moving average of $289.85 and a two-hundred day moving average of $322.50.

The Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter in the previous year, the firm earned $6.79 EPS. On average, research analysts anticipate that The Cigna Group will post 29.8 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be given a dividend of $1.51 per share. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 dividend on an annualized basis and a yield of 2.06%. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s dividend payout ratio (DPR) is 45.75%.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.